Pharma in review: trending stories 7/19/19

July 19, 2019

FDA accuses Indian co. of shredding docs before inspection

Officials at Strides Pharma Science Ltd. appear to have attempted to destroy quality-control documents. 

J&J facing criminal investigation in ongoing talc scandal

The Department of Justice is reportedly investigating claims that J&J officials lied about cancer risks tied to its popular baby powder. 
FDA hands Eton Pharma CRL for eye drops

The Complete Response Letter means the agency will not approve the application or abbreviated application in its present form.

Product Focus: Advancing aseptic processing

How the pharma industry's big ideas are impacting sterile manufacturing.

Gilead inks $5B deal with Galapagos to bolster anti-inflammatories pipeline

Gilead will invest $5.1 billion into its ongoing partnership with Galapagos NV, a Belgo-Dutch company that specializes in research and development of small molecule medicines